10.1 Recovery-Oriented Systemic Care for Substance Use Disorders

Episodic Treatment Versus a Recovery-Oriented System

The distinction task 03.11 rests on is between two models of care.

Acute episode of care. The person is admitted, treated for a defined period, discharged, and considered a success or a failure at follow-up. Relapse is treated as treatment failure or as the client's failure.

Recovery-oriented system of care. Substance use disorder is managed as a chronic condition. Care is continuous rather than episodic, the person directs their own recovery goals, non-clinical supports count as care, and relapse is treated as a signal to adjust the plan rather than as a discharge event.

The exam tests the second model. Options that terminate treatment on a relapse, that require abstinence as a condition of continued therapy, or that treat the person's own recovery goals as negotiable are distractors.

SAMHSA's working definition — a process of change through which individuals improve health and wellness, live self-directed lives, and strive to reach their full potential — is anchored by four dimensions:

• Health. Managing the condition and making informed, healthy choices.
• Home. A stable and safe place to live.
• Purpose. Meaningful daily activity and the independence, income, and resources to participate in society.
• Community. Relationships and social networks that provide support, friendship, love, and hope.

Two of the four are explicitly relational, which is why family therapy is not adjunctive in this model but central.

Where the Family Sits

Families of people with substance use disorders are simultaneously affected, protective, and pattern-maintaining, and effective work addresses all three.

• Affected. Partners and children carry documented elevated rates of depression, anxiety, and trauma exposure, and deserve care in their own right rather than only as instruments of the user's recovery.
• Protective. Family support is one of the strongest predictors of treatment entry and sustained recovery.
• Pattern-maintaining. Accommodation — covering absences, paying consequences, adjusting the household around use — reduces short-term family distress while removing the pressure that motivates change.

The older clinical vocabulary of codependency and enabling appears in prep materials but is used carefully on the exam, because it locates pathology in family members rather than describing an interactional pattern. Prefer accommodation and reinforcement contingencies, which describe the same behavior without assigning a character defect.

Evidence-Based Family Interventions

CRAFT is the highest-yield item on this list. Comparative trials place its treatment-entry rates well above both the Johnson Institute confrontational intervention and Al-Anon facilitation, while producing better functioning in the concerned significant other regardless of whether the user enters treatment. The confrontational "surprise intervention" is the distractor the exam builds around, because it is culturally familiar and empirically weak, with high dropout and relational damage.

Motivational Stance and Stages of Change

Prochaska and DiClemente's transtheoretical model — precontemplation, contemplation, preparation, action, maintenance, with relapse as a normal feature of the cycle — supplies the vocabulary. The clinical rule is to match the intervention to the stage: giving action-stage advice to a precontemplative client generates what looks like resistance but is a mismatch created by the therapist.

Motivational interviewing supplies the method: express empathy, develop discrepancy between behavior and values, roll with resistance rather than arguing, and support self-efficacy. On the exam, an option in which the therapist confronts denial or presents evidence to overcome it is nearly always wrong.

Medications, Mutual Aid, and Harm Reduction

Medications for opioid use disorder are first-line treatment. Methadone and buprenorphine are opioid agonists or partial agonists that reduce craving and overdose mortality; naltrexone is an antagonist available in oral and extended-release injectable forms. Acamprosate, naltrexone, and disulfiram are the alcohol-use-disorder medications.

The testable position: medication is treatment, not substitution. Families and some mutual-aid communities sometimes assert that a person on buprenorphine is not truly in recovery. A therapist's role is psychoeducation correcting that belief, not endorsement of it. Coordination with the prescriber, within the boundaries of the therapist's competence under task 03.21, is the expected action.

Mutual aid includes Alcoholics Anonymous, Narcotics Anonymous, SMART Recovery, and for families Al-Anon, Nar-Anon, and Alateen. These are supports to be offered, not requirements to be imposed; mandating a specific spiritually framed program over a client's objection raises both competence and autonomy concerns.

Harm reduction — naloxone distribution and training, safer-use education, syringe services, overdose planning — is part of a recovery-oriented system and is not in conflict with abstinence goals. Family naloxone training is a concrete, defensible intervention in a household with opioid use.

Monitoring the Plan

Task 03.11 says "develop and monitor." Monitoring is what makes care continuous:

• Recovery capital tracking across the four dimensions rather than abstinence days alone.
• An explicit, written relapse response plan agreed in advance by the family, specifying who is called, what changes in the treatment plan, and what does not change, so that a return to use triggers a rehearsed response instead of a crisis.
• Regular review of accommodation patterns as they re-form.
• Screening at each review for the elevated suicide risk that accompanies substance use disorders and spikes after a relapse.